Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Reports Record Operating Earnings for the Third Quarter 2005
Integra LifeSciences Reports Record Operating Earnings for the Third Quarter 2005 PLAINSBORO, N.J., Oct. 30, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its third quarter financial results. Total revenues in the third quarter of 2005 were $69.3
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Monday, October 31 to Discuss Third Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Monday, October 31 to Discuss Third Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 18, 2005--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting
Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting PLAINSBORO, N.J., Oct. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it is featuring the AccuDrain™ External CSF Drainage
View HTML
Toggle Summary Integra Foundation Donates $130,000 for Hurricane Katrina Relief Effort
Integra Foundation Donates $130,000 for Hurricane Katrina Relief Effort PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- In response to the overwhelming devastation of Hurricane Katrina, the Integra Foundation, the philanthropic arm of Integra LifeSciences Holdings Corporation (Nasdaq:IART), has made
View HTML
Toggle Summary Integra NeuroSciences Launches New Non-Stick Bipolar Forceps
Integra NeuroSciences Launches New Non-Stick Bipolar Forceps PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will market and sell the Integra BUZZ™ non-stick bipolar forceps.
View HTML
Toggle Summary Integra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting
Integra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting PLAINSBORO, N.J., Oct. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the Integra NPH™ Low Flow Hydrocephalus Valve
View HTML
Toggle Summary Integra LifeSciences Acquires Eunoe Inc.'s Intellectual Property Estate
Integra LifeSciences Acquires Eunoe Inc.'s Intellectual Property Estate PLAINSBORO, N.J., Sept. 29, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the intellectual property estate of Eunoe, Inc.
View HTML
Toggle Summary Integra Introduces Line Extension for Nerve Injury Products
Integra Introduces Line Extension for Nerve Injury Products PLAINSBORO, N.J., Sept. 23, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has enhanced its product offering for the treatment of peripheral nerve injuries.
View HTML
Toggle Summary Integra LifeSciences Announces Agreement to Acquire Radionics Division of Tyco Healthcare Group, L.P.
Integra LifeSciences Announces Agreement to Acquire Radionics Division of Tyco Healthcare Group, L.P. PLAINSBORO, N.J., Sept. 7, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the assets of the Radionics Division of Tyco
View HTML
Toggle Summary Integra LifeSciences Reports Record Revenues for the Second Quarter 2005
Integra LifeSciences Reports Record Revenues for the Second Quarter 2005 PLAINSBORO, N.J., Aug. 7, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its second quarter financial results. Total revenues in the second quarter of 2005 were $69.8 million,
View HTML